Home » Topics » Regulatory

Regulatory
RSS

The FDA approves Viadur for once-yearly palliative treatment of advanced prostate cancer

March 10, 2000

New nondrug treatment approved for rheumatoid arthritis in Canada

March 10, 2000

New formulation of Agouron's Viracept approved in U.S.

March 10, 2000

Pharmacia & Upjohn submits applications for once-daily Detrol formulation

March 10, 2000

AMBI to receive patent for use of calcium taurate with antihypertensive agents

March 10, 2000

The FDA approves once-daily Singulair tablet for treatment of asthma in young children

March 9, 2000

Solid oral formulations of eprosartan with enhanced bioavailability

March 9, 2000

Use of secretin for autism receives broad patent coverage

March 7, 2000

European mutual recognition approval obtained for candesartan/HCTZ combination

March 7, 2000

Noven successfully completes phase II study of MethyPatch for treatment of ADHD

March 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.